| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 52,586 | 61,106 | 67,579 | 82,623 | | Cost of Revenue | 40,096 | 46,477 | 48,852 | 67,318 | | | Gross Profit | 12,490 | 14,629 | 18,727 | 15,305 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,679 | 11,847 | 11,855 | 12,306 | | Non Recurring |
-
|
-
|
-
| 2,788 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,811 | 2,782 | 6,872 | 211 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 262 | 2,676 | 6,872 | 216 | | Interest Expense | (1,218) | 530 | 688 | 813 | | Income Before Tax | 1,480 | 2,146 | 6,184 | (597) | | Income Tax Expense | 785 | (1,605) | 178 | 230 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 629 | 3,751 | 6,006 | (827) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 695 | 3,751 | 6,006 | (827) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $695 | $3,751 | $6,006 | ($827) |
|
0.51% Nasdaq 0.00%
Income Statement
